Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model. Kuo CY, Liao TL, Hsu FT, Chang CM, et al. Anticancer Res 2026;46:797-810.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kuo CY, Liao TL, Hsu FT, Chang CM, et al. Lenvatinib Exhibits Potent Anti-tumor Activity and Favorable Safety Profile in a Colorectal Cancer Xenograft Model. Anticancer Res 2026;46:797-810.
PMID: 41617418